Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study
Author(s) -
Alexandros N. Vgontzas,
Kristina Puzino,
Julio FernándezMendoza,
Venkatesh Basappa Krishnamurthy,
Maria Basta,
Edward O. Bixler
Publication year - 2020
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8740
Subject(s) - trazodone , medicine , actigraphy , insomnia , primary insomnia , cognitive behavioral therapy , randomized controlled trial , sleep disorder , physical therapy , psychiatry , antidepressant , hippocampus
The insomnia with objective short sleep duration phenotype is associated with increased risk for adverse health outcomes, physiological hyperarousal, and a blunted response to cognitive behavioral therapy for insomnia (CBT-I). Whether insomnia with objective short sleep duration responds better to pharmacological treatment compared to CBT-I has not been examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom